AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
Article Link
Collect
Submit Manuscript
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Review

Organ-on-a-chip in natural product research: advancing translational ADME, efficacy and safety assessment

Lijun Hao, Ye Ge, Tingting Wang, Guangji Wang( ), Jingwei Zhang( )
State Key Laboratory of Natural Medicines, Key Laboratory of Drug Metabolism and Pharmacokinetics, China Pharmaceutical University, Nanjing 210009, China
Show Author Information

Abstract

Natural products exhibit complex in vivo behaviors governed by dynamic exposure, multi-target interactions, and inter-organ crosstalk, which conventional preclinical models often fail to capture. Organ-on-a-chip (OOC) technologies provide human-relevant in vitro platforms that integrate physiological flow, tissue architecture, and multicellular interactions. This review systematically summarizes recent advances in gut, liver, and multi-organ chip systems for investigating key processes underlying the absorption, metabolism, and systemic exposure of natural products. We further highlight the application of disease-specific OOC models in evaluating pharmacological responses under pathophysiological conditions and assessing organ-specific and immune-related safety risks of natural products. Finally, we discuss current challenges and future directions for OOC-based natural product research, including prioritizing functional biomarker-based standardization, incorporating patient-specific cell sources, engineering systems tailored to the complexity of natural products, and exploring emerging research frontiers, all anchored in mechanistic in vitro-in vivo extrapolation (IVIVE) and quantitative systems pharmacology frameworks toward predictive Digital Twins. Collectively, OOC platforms provide a systematic and translational framework for studying the complex pharmacokinetics and biological effects of natural products.

CLC number: R284

References

【1】
【1】
 
 
Chinese Journal of Natural Medicines
Pages 1431-1443

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Close
Close
Cite this article:
Hao L, Ge Y, Wang T, et al. Organ-on-a-chip in natural product research: advancing translational ADME, efficacy and safety assessment. Chinese Journal of Natural Medicines, 2026, 24(12): 1431-1443. https://doi.org/10.1016/S1875-5364(26)61231-9

8

Views

0

Crossref

0

Web of Science

0

Scopus

0

CSCD

Received: 19 February 2026
Revised: 13 April 2026
Accepted: 17 June 2026
Published: 20 December 2026
© 2026, China Pharmaceutical University.